Trigger Versus Substrate Ablation for Atrial Fibrillation.

Area of Science:

• Electrophysiology
• Cardiovascular Medicine
• Medical Technology

Background:

• Catheter ablation is a primary treatment for atrial fibrillation (AF).
• Pulmonary vein ablation effectively treats paroxysmal AF but shows limited success in non-paroxysmal forms.
• This necessitates exploring alternative ablation targets beyond simple trigger elimination.

Purpose of the Study:

• To review current strategies for catheter ablation of atrial fibrillation (AF).
• To discuss the shift towards targeting AF substrates in addition to triggers.
• To highlight emerging targets and future directions in AF ablation.

Main Methods:

• Review of existing literature on catheter ablation for atrial fibrillation.
• Analysis of studies investigating pulmonary vein ablation for paroxysmal and non-paroxysmal AF.
• Examination of research on substrate modification targets, including complex fractionated electrograms, dominant frequency sites, and autonomic ganglionated plexi.

Main Results:

• Pulmonary vein ablation is effective for paroxysmal AF.
• Efficacy of pulmonary vein ablation is less convincing for non-paroxysmal AF.
• Alternative targets like complex fractionated electrograms and autonomic ganglionated plexi are under investigation.

Conclusions:

• Current AF ablation strategies require refinement, especially for non-paroxysmal forms.
• Targeting AF substrates represents a promising area for future research and clinical application.
• Further clinical studies are needed to establish the mainstream use of these novel ablation targets.